Jenburkt Pharmaceuticals standalone net profit rises 24.09% in the March 2024 quarter

Sales rise 10.34% to Rs 38.84 crore

Net profit of Jenburkt Pharmaceuticals rose 24.09% to Rs 7.88 crore in the quarter ended March 2024 as against Rs 6.35 crore during the previous quarter ended March 2023. Sales rose 10.34% to Rs 38.84 crore in the quarter ended March 2024 as against Rs 35.20 crore during the previous quarter ended March 2023.

For the full year,net profit rose 5.57% to Rs 25.98 crore in the year ended March 2024 as against Rs 24.61 crore during the previous year ended March 2023. Sales rose 3.82% to Rs 141.97 crore in the year ended March 2024 as against Rs 136.75 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales38.8435.20 10 141.97136.75 4 OPM %25.3621.25 -23.3322.21 - PBDT10.988.66 27 37.5235.12 7 PBT10.368.07 28 35.1832.86 7 NP7.886.35 24 25.9824.61 6

Powered by Capital Market - Live News